Anticonvulsant effects by combined treatment with a glycine, receptor antagonist and a polyamine site antagonist in amygdala-kindled rats

European Journal of Pharmacology

Volumn 322, Issue 2-3, 1997, Pages 179-184

  Ebert, Ulrich ^a   Wlaź, Piotr ^a,b   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

Author keywords

Complex partial seizure; Electrical kindling; Epilepsy; NMDA receptor

Indexed keywords

7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; GLYCINE RECEPTOR ANTAGONIST; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING SITE; COMPLEX PARTIAL SEIZURE; DISEASE SEVERITY; DRUG ACTIVITY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYGDALA; ANIMALS; ANTICONVULSANTS; FEMALE; KINDLING, NEUROLOGIC; POLYAMINES; PYRROLIDINONES; QUINOLONES; RATS; RATS, WISTAR; RECEPTORS, GLYCINE;

EID: 0030986117     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00084-8     Document Type: Article

References (34)

1. Bristow, L.J., Hutson, P.H., Kulagowski, J.J., Leeson, P.D., Matheson, S., Murray, F., Rathbone, D., Saywell, K.L., Thorn, L., Watt, A.P., Tricklebank, M.D., 1996. The anticonvulsant and behavioural profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. J. Pharmacol. Exp. Ther. 279, 492-501.
2. Carter, A.J., 1992. Glycine antagonists: regulation of the NMDA receptor-channel complex by strychnine-insensitive glycine site. Drugs Future 17, 595-613.
3. 2+ channels in rat and mouse cultured hippocampal pyramidal neurones: comparison with N-methyl-D-aspartate receptor antagonist actions. Br. J. Pharmacol. 113, 499-507.
4. Deren-Wesolek, A., Maj, J., 1993. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex. Pol. J. Pharmacol. 45, 467-480.
5. De Sarro, G.B., De Sarro, A., 1992. Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene. Neuropharmacology 32, 51-58.
6. De Sarro, G.B., Bagetta, G., Spagnolo, C., Nistico, G., 1992. Antagonists of N-methyl-D-aspartate receptors block seizures induced by putrescine in the deep prepiriform cortex. Neuropharmacology 32, 43-50.
7. Doyle, K.M., Shaw, G.G., 1996. Investigation of the involvement of the N-methyl-D-aspartate receptor macrocomplex in the development of spermine-induced CNS excitation in vivo. Br. J. Pharmacol. 117, 1803-1808.
8. Freeman, F.G., Jarvis, M.F., 1981. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res. Bull. 7, 629-633.
9. Johnson, T.D., 1996. Modulation of channel function by polyamines. Trends Pharmacol. Sci. 17, 22-27.
10. Johnson, J.W., Ascher, P., 1987. Glycine potentiates the NMDA response in cultured mouse brain neurones. Nature 325, 529-531.
11. Kemp, J.A., Leeson, P.D., 1993. The glycine site of the NMDA receptor-five years on. Trends Pharmacol. Sci. 14, 20-25.
12. Kulagowski, J.J., Baker, R., Curtis, N.R., Leeson, P.D., Mawer, I.M., Moseley, A.M., Ridgill, M.P., Rowley, M., Stansfield, I., Foster, A.C., Grimwood, S., Hill, R.G., Kemp, J.A., Marshall, G.R. Saywell, K.L., Tricklebank, M.D., 1994. 3′-(Arylmethyl-) and 3′-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(H)-ones: orally active antagonists of the glycine site on the NMDA receptor complex. J. Med. Chem. 37, 1402-1405.
13. Löscher, W., Hönack, D., 1990. The effect of interstimulation interval on the assessment of anticonvulsant drug potency in fully kindled rats. Epilepsy Res. 7, 182-196.
14. Löscher, W., Hönack, D., 1991. Anticonvulsant and behavioural effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther. 256, 432-440.
15. Löscher, W., Schmidt, D., 1988. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2, 145-181.
16. Löscher, W., Schmidt, D., 1994. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res. 17, 95-134.
17. Löscher, W., Rundfeldt, C., Hönack, D., 1993. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur. J. Neurosci. 5, 1545-1550.
18. Löscher, W., Wlaź, P., Rundfeldt, C., Baran, H., Hönack, D., 1994. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats. Br. J. Pharmacol. 112, 97-106.
19. 3H]Dizolcipine association kinetics distinguish stimulatory and inhibitory polyamine sites of N-methyl-D-aspartate receptors. J. Neurochem. 63, 963-971.
20. McAllister, K.M., 1992. N-Methyl-D-aspartate receptor antagonists and channel blockers have different effects upon a spinal seizure model in mice. Eur. J. Pharmacol. 211, 105-108.
21. 3 receptor. Neuropharmacology 34, 621-629.
22. Morimoto, K., Sato, M., 1992. NMDA receptor complex and kindling mechanisms. In: Engel Jr., J., Wasterlain, C., Cavalheiro, E.A., Heinemann, U., Avanzini, G. (Eds.), Molecular Neurobiology of Epilepsy. Elsevier, Amsterdam, pp. 297-305.
23. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, Sydney.
24. Racine, R.J., 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281-294.
25. Ransom, R.W., 1992. Polyamine and ifenprodil interactions with the NMDA receptor's glycine site. Eur. J. Pharmacol. 208, 67-71.
26. 3H]MK-SOl binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine, and polyamines. J. Neurochem. 51, 830-836.
27. Rogawski, M.A., 1992. The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs 44, 279-292.
28. Rundfeldt, C., Wlaź, P., Löscher, W., 1994. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy. Brain Res. 653, 125-130.
29. 3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex. Eur. J. Pharmacol. 176, 249-250.
30. Sveinbjornsdottir, S., Sander, J.W.A.S., Upton, D., Thompson, P.J., Patsalos, P.N., Hirt, D., Emre, M., Lowe, D., Duncan, J.S., 1993. The excitatory amino acid antagonist D-CCP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res. 16, 165-174.
31. Voltz, C., Page, D., Carter, C., 1994. Synergism between the NMDA receptor antagonistic effects of ifenprodil and the glycine antagonist, 7-chlorokynurenate, in vivo. Eur. J. Pharmacol. 255, 197-202.
32. Williams, K., 1993. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44, 851-859.
33. Wlaź, P., Ebert, U., Löscher, W., 1994. Low doses of the glycine/NMDA receptor antagonist R-(+)-HA-966 but not D-cycloserine induce paroxysmal activity in limbic brain regions of kindled rats. Eur. J. Neurosci. 6, 1710-1719.
34. Zarnowski, T., Kleinrok, Z., Turski, W.A., Czuczwar, S.J., 1994. The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice. J. Neural Transm. Gen. Sect. 97, 1-12.